Latest News and Press Releases

LEIDEN, Netherlands, March 6, 2014 (GLOBE NEWSWIRE) -- Revenues and other income decreased to €7.0 million (2012: €10.9 million) mainly as a result from lower license fees as 2012...

LEIDEN, Netherlands and RALEIGH, N.C., Feb. 24, 2014 (GLOBE NEWSWIRE) -- Pharming Group NV (NYSE Euronext:PHARM) and Salix Pharmaceuticals, Ltd. (Nasdaq:SLXP) today announced that the Food and Drug...

LEIDEN, Netherlands and SAN DIEGO, Nov. 8, 2013 (GLOBE NEWSWIRE) -- Pharming Group NV (NYSE Euronext: PHARM) and Santarus, Inc. (NASDAQ: SNTS) announced that new data from an open-label extension of...

LEIDEN, Netherlands, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today published its financial report for the first nine...

LEIDEN, Netherlands, Oct. 9, 2013 (GLOBE NEWSWIRE) -- Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announced that it has entered into a private...

LEIDEN, Netherlands, Aug. 17, 2006 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming") (Euronext:PHARM) (PHARM.AS) announced today that its Marketing Authorization Application (MAA) for...

LEIDEN, Netherlands, Nov. 17, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that the Company presented clinical...

LEIDEN, Netherlands, Nov. 09, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that it has been selected by Euronext...

LEIDEN, Netherlands, Nov. 3, 2005 (PRIMEZONE) -- Highlights: upcoming product filings, licensing progress and pipeline expansion. Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM)...

LEIDEN, Netherlands, Oct. 24, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that it has appointed Mr. Wim J. E....